Literature DB >> 7675553

Short-term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: a cross-over randomized study.

C Braggion1, L M Cappelletti, M Cornacchia, L Zanolla, G Mastella.   

Abstract

The aim of our study was to compare the short-term efficacy of three different chest physiotherapy (CPT) regimens (PD, postural drainage; PEP, positive expiratory pressure physiotherapy; HFCC, high-frequency chest compression physiotherapy) on patients with cystic fibrosis (CF) hospitalized for an acute pulmonary exacerbation. Sixteen patients with CF, 8 males, 8 females, aged 15-27 years (mean, 20.3 +/- 4), met the inclusion criteria: 1) age over 14 years; 2) mild or moderate airway obstruction; 3) sputum volume > 30 mL/day; 4) being proficient in PD and PEP CPT. Patients at admission had (mean +/- SD) forced volume in 1 second (FEV1) 52.2 +/- 21.9 percent predicted; Shwachman-Kulczycki clinical score 65.1 +/- 11 points; Chrispin-Norman chest radiography score 18.6 +/- 4.3 points. The three CPT regimens and a control-treatment (CONT) were administered in a random sequence, each patient receiving each treatment twice a day (in 50 minute sessions) for 2 consecutive days. During CONT and for 30 minutes after each session only spontaneous coughing was allowed. Wet and dry weight of sputum were recorded during the 50-minute sessions and 30 minutes afterward. Lung function was measured before and 30 minutes after each session. For each treatment a score was given by the patient for efficacy, and by both the patient and the physiotherapist for tolerance. Wet and dry weights of sputum collected during the sessions were greater for all CPT regimens than for CONT (P < 0.001, P < 0.0001). No significant differences between the three CPT regimens for both wet and dry weights were found when the number of coughs was taken into account.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675553     DOI: 10.1002/ppul.1950190104

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  21 in total

Review 1.  Cystic fibrosis.

Authors:  P Robinson
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

Review 2.  Physiotherapy in cystic fibrosis.

Authors:  S A Prasad; E L Tannenbaum; C Mikelsons
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

3.  Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis.

Authors:  A E Holland; L Denehy; G Ntoumenopoulos; M T Naughton; J W Wilson
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

4.  Oscillating devices for airway clearance in people with cystic fibrosis.

Authors:  Lisa Morrison; Stephanie Milroy
Journal:  Cochrane Database Syst Rev       Date:  2020-04-30

Review 5.  Structure and function of the mucus clearance system of the lung.

Authors:  Brenda M Button; Brian Button
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

Review 6.  Oscillating devices for airway clearance in people with cystic fibrosis.

Authors:  Lisa Morrison; Stephanie Innes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-04

Review 7.  Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.

Authors:  E Main; A Prasad; C Schans
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

8.  Airway clearance devices for cystic fibrosis: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

9.  Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease.

Authors:  Kristina Brooks; Regine L Caruthers; Kurt R Schumacher; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2013-05-17       Impact factor: 4.705

10.  Effects of changes in lung volume on oscillatory flow rate during high-frequency chest wall oscillation.

Authors:  Scott J Butcher; Michal P Pasiorowski; Richard L Jones
Journal:  Can Respir J       Date:  2007-04       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.